ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹5.05 Cr | ₹2.75 Cr | ₹52 Cr | ₹162 Cr | ₹361 Cr |
What is the latest Total Non-Current Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹5.05 Cr |
Mar2024 | ₹2.75 Cr |
Mar2023 | ₹52 Cr |
Mar2022 | ₹162 Cr |
Mar2021 | ₹361 Cr |
How is Total Non-Current Liabilities of ALEMBIC PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹5.05 Cr | 83.64 | |
Mar2024 | ₹2.75 Cr | -94.75 | |
Mar2023 | ₹52 Cr | -67.66 | |
Mar2022 | ₹162 Cr | -55.13 | |
Mar2021 | ₹361 Cr | - |
Compare Total Non-Current Liabilities of peers of ALEMBIC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC PHARMACEUTICALS | ₹19,668.8 Cr | -4% | 2.8% | 3.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹183,268.0 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC PHARMACEUTICALS | -4% |
2.8% |
3.3% |
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses